the 4 pts you saw before the approval will go away ..from 126 a share I excpect a %10 haircut... so 110-114 a share... don't forget %95 o shares are held by institutions... they tend to dump reckless...
Sadly I think vacinemaxine is right. This was completely expected. They had a 12-1 approval vote at the panel meeting and the premium has been built in. This is good news but expected news. Any pop I expect to be small, maybe to $132 then will pull back but probably not a "huge flush" like you say.
im seeing this goin down...lots of sellers linin up plus I don't think most understand the pricing n how it takes away from the first drug.... this could be a huge flush !!
Just gauging how previous FDA approvals have played out in my experience this will be a sell the news, pricing needed to be over 300k per year for a bullish outcome. Just my take, I have no position.